Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
American Journal of Nuclear Medicine and Molecular Imaging|December 17, 2020
Positron emission tomography objective parameters for assessment of left ventricular assist device infection using <sup>18</sup>F-FDG PET/CTSaul N Friedman, Maryam Mahmood, Jennifer R Geske, et al.
Plos One|May 3, 2023
Parkin-mediated mitophagy is negatively regulated by FOXO3A, which inhibits Plk3-mediated mitochondrial ROS generation in STZ diabetic stress-treated pancreatic β cellsJi Yeon Shim, Jin Ook Chung, Dawa Jung, et al.
American Journal of Nuclear Medicine and Molecular Imaging|September 16, 2017
Head and neck PET/CT therapy response interpretation criteria (Hopkins criteria) - external validation studyAyse Tuba Kendi, David Brandon, Jeffrey Switchenko, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|September 16, 2017
Role of <sup>18</sup>F-FDG PET/CT in the diagnosis of cardiovascular implantable electronic device infections: A meta-analysisMaryam Mahmood, Ayse Tuba Kendi, Saira Farid, et al.
Clinical Genitourinary Cancer|February 26, 2021
Radium-223 in the Third-Line Setting in Metastatic Castration-Resistant Prostate Cancer: Impact of Concomitant Use of Enzalutamide on Overall Survival (OS) and Predictors of Improved OSMohamed E Ahmed, Vidhu B Joshi, Mohamed Badawy, et al.
Annals of Nuclear Medicine|September 17, 2024
Detection rate of gastrin-releasing peptide receptor (GRPr) targeted tracers for positron emission tomography (PET) imaging in primary prostate cancer: a systematic review and meta-analysisGokce Belge Bilgin, Cem Bilgin, Atakan Orscelik, et al.
The Oncologist|January 26, 2021
Treatment Outcomes of Well-Differentiated High-Grade Neuroendocrine TumorsAlex J Liu, Benjamin E Ueberroth, Patrick W McGarrah, et al.
Theranostics|April 22, 2024
Theranostics and artificial intelligence: new frontiers in personalized medicineGokce Belge Bilgin, Cem Bilgin, Brian J Burkett, et al.
EJNMMI Research|October 15, 2024
All that glitters is not gold: high uptake on PSMA PET in non-prostate cancers does not mean that treatment with [<sup>177</sup>Lu]Lu-PSMA-radioligand will be successfulTrond Velde Bogsrud, Ola Engelsen, Thuy Thu Thi Lu, et al.
Radiology|November 24, 2020
How We Do It: A Multidisciplinary Approach to <sup>177</sup>Lu DOTATATE Peptide Receptor Radionuclide TherapyBrian J Burkett, Ayca Dundar, Jason R Young, et al.
Pageof 9